A new diabetes drug has been approved by the US Food and Drug Administration for use as a weight-loss drug.
by ALEXX ALTMAN-DEVILBISS | The National DeskFILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26, 2017. The drug by Eli Lilly and Co. is called Mounjaro for diabetes but will be renamed Zepbound for weight loss, according to a news release from the FDA.
Zepbound was approved by the FDA for people who are considered obese, with a body mass index of 30 or higher or those who are overweight with a related health condition, like high blood pressure, high cholesterol or diabetes. “Obesity and overweight are serious conditions that can be associated with some of the leading causes of death such as heart disease, stroke and diabetes,” Dr. John Sharretts, the FDA’s director of the Division of Diabetes, Lipid Disorders, and Obesity, said. “In light of increasing rates of both obesity and overweight in the United States, today’s approval addresses an unmet medical need.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
New weight loss drug: FDA approves Zepbound, a version of diabetes drug Mounjaro for obesityZepbound, a new version of the popular diabetes treatment Mounjaro, can now be sold as a weight-loss drug and helped patients lose 25% of their weight.
Weiterlesen »
FDA approves new version of diabetes drug Mounjaro for weight lossSetting—and sticking to—a holiday budget could help you avoid finical hardship down the road.
Weiterlesen »
FDA approves new version of diabetes drug Mounjaro for weight lossThe Spurs are on a two-game losing skid.
Weiterlesen »
FDA approves new version of diabetes drug Mounjaro for weight lossThe Crescent Hotel will hold a soft opening on Wednesday.
Weiterlesen »
FDA approves new version of diabetes drug Mounjaro for weight lossThe Jacksonville Aviation Authority is holding a disaster exercise near the airport Wednesday. Road closures will be happening from 9 a.m. to 10:45 a.m.
Weiterlesen »
FDA approves new version of diabetes drug Mounjaro for weight lossThe Food and Drug Administration approved Zepbound, a new version of the popular diabetes treatment Mounjaro which helps dieters lose about a quarter of their body weight.
Weiterlesen »